Protamine-induced acute thrombosis in a post-TAVR patient: A word of caution.
Citation: Cardiovascular Revascularization Medicine. 2022 Jun 10PMID: 35779996Institution: MedStar Heart & Vascular Institute | MedStar Washington Hospital Center | MedStar Washington Hospital CenterDepartment: Internal Medicine Residency | Interventional Cardiology FellowshipForm of publication: Journal ArticleMedline article type(s): Case ReportsSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2022Local holdings: Available in print through MWHC library: 2002 - presentISSN:- 1878-0938
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 35779996 | Available | 35779996 |
Available in print through MWHC library: 2002 - present
Major vascular complications after transcatheter aortic valve replacement (TAVR) are a pertinent issue and associated with increased morbidity and mortality. We herein describe a case of acute limb ischemia following the administration of protamine sulfate (PS) that was administered to mitigate a bleeding complication post-failure of a vascular access closure device. PS should be used cautiously for the prevention or management of bleeding-site complications following TAVR. The patient described in this case has consented to having his case described in this manuscript. Copyright © 2022. Published by Elsevier Inc.
English